DCTH
Delcath Systems, Inc.Company with tickers: DCTH
CIK
872912
CUSIP
24661P807
Shares Outstanding
34,521,647
Website
https://www.delcath.com
13F Activity (30d)
8 filings
6 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $24,994,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $3,736,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | $21,258,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $22,895,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $9,824,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-1,637,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-1,070,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| United States | $32,303,000 | $78,835,000 |
| Non Us | $4,902,000 | $6,396,000 |
By Product & Service (USD)
| Component | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| HEPZATOKIT | — | — | — | $0 | $32,303,000 | $78,835,000 |
| CHEMOSAT | — | — | — | $2,065,000 | $4,902,000 | $6,396,000 |
| Product And Service Other | $490,000 | $2,255,000 | $171,000 | — | — | — |
| Product | $1,156,000 | $1,300,000 | $2,548,000 | — | — | — |